Xiangmin Cui's most recent trade in Nuvation Bio Inc - Ordinary Shares - Class A was a trade of 12,879,200 Class A Common Stock done . Disclosure was reported to the exchange on Sept. 3, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | 03 Sep 2024 | 12,879,200 | 17,062,202 | - | - | Class A Common Stock | ||
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | 03 Sep 2024 | 5,157,900 | 7,611,031 | - | - | Class A Common Stock | ||
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | 03 Sep 2024 | 967,100 | 1,281,206 | - | - | Class A Common Stock | ||
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 437,834 | 437,834 | - | - | Warrants (Right to Buy) | |
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 175,346 | 175,346 | - | - | Warrants (Right to Buy) | |
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 128,792 | 128,792 | - | - | Series A Preferred Stock | |
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | 03 Sep 2024 | 128,792 | 0 | - | - | Series A Preferred Stock | ||
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 51,579 | 51,579 | - | - | Series A Preferred Stock | |
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | 03 Sep 2024 | 51,579 | 0 | - | - | Series A Preferred Stock | ||
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 32,877 | 32,877 | - | - | Warrants (Right to Buy) | |
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 9,671 | 9,671 | - | - | Series A Preferred Stock | |
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | 03 Sep 2024 | 9,671 | 0 | - | - | Series A Preferred Stock | ||
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | Purchase of securities on an exchange or from another person at price $ 2.97 per share. | 25 Jun 2024 | 277,895 | 2,453,131 | - | 3.0 | 825,348 | Class A Common Stock |
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | Purchase of securities on an exchange or from another person at price $ 2.98 per share. | 20 Jun 2024 | 336,874 | 2,175,236 | - | 3.0 | 1,003,885 | Class A Common Stock |
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | Purchase of securities on an exchange or from another person at price $ 2.99 per share. | 20 Jun 2024 | 87,715 | 1,762,951 | - | 3.0 | 262,268 | Class A Common Stock |
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 20 Jun 2024 | 75,411 | 1,838,362 | - | 3 | 226,233 | Class A Common Stock |
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2024 | 4,183,002 | 4,183,002 | - | - | Class A Common Stock | |
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2024 | 1,675,236 | 1,675,236 | - | - | Class A Common Stock | |
Nuvation Bio Inc - Ordinar... | Xiangmin Cui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2024 | 314,106 | 314,106 | - | - | Class A Common Stock | |
Cue Health Inc | Xiangmin Cui | Director | 28 Sep 2021 | 8,192,468 | 8,192,468 | - | - | Common Stock | ||
Cue Health Inc | Xiangmin Cui | Director | 28 Sep 2021 | 8,192,468 | 0 | - | - | Series C-1 Preferred Stock | ||
Cue Health Inc | Xiangmin Cui | Director | Grant, award, or other acquisition of securities at price $ 12.80 per share. | 28 Sep 2021 | 788,441 | 788,441 | - | 12.8 | 10,092,045 | Common Stock |